Drug development: The cell wall as a drug target

Drug development: The cell wall as a drug target

Bibliographic Details
Main Author:	Jonathan A.G Cox
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-01-01
Series:	International Journal of Mycobacteriology
Online Access:	http://www.ijmyco.org/article.asp?issn=2212-5531;year=2016;volume=5;issue=5;spage=156;epage=156;aulast=Cox

Similar Items

Mycobacterial Cell Wall: A Source of Successful Targets for Old and New Drugs
by: Catherine Vilchèze
Published: (2020-03-01)

Novel drug targets in cell wall biosynthesis exploited by gene disruption in Pseudomonas aeruginosa.
by: Ayssar A Elamin, et al.
Published: (2017-01-01)

Degranulation of Mast Cells as a Target for Drug Development
by: Bo-Gie Yang, et al.
Published: (2023-05-01)

PRE-CLINICAL DEVELOPMENT OF HUMAN MONOCLONAL ANTIBODIES TARGETING NOVEL, CELL WALL PROTEINS IN DRUG RESISTANT FUNGAL PATHOGENS
by: S. Palliyil, et al.
Published: (2023-05-01)

The Aspergillus fumigatus cell wall integrity signalling pathway: drug target, compensatory pathways and virulence
by: Vito eValiante, et al.
Published: (2015-04-01)

Machine Learning Prediction of Mycobacterial Cell Wall Permeability of Drugs and Drug-like Compounds
by: Eugene V. Radchenko, et al.
Published: (2023-01-01)

Multi-target drugs: the trend of drug research and development.
by: Jin-Jian Lu, et al.
Published: (2012-01-01)

Novel drug targets for Mycobacterium tuberculosis: 2-heterostyrylbenzimidazoles as inhibitors of cell wall protein synthesis
by: Mohana Rao Anguru, et al.
Published: (2017-07-01)

Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development
by: Knut Biber, et al.
Published: (2019-08-01)

Fungal Cell Wall: Emerging Antifungals and Drug Resistance
by: Soraia L. Lima, et al.
Published: (2019-11-01)

Aquaporins in Immune Cells and Inflammation: New Targets for Drug Development
by: Inês V. da Silva, et al.
Published: (2021-02-01)

Addressing Antiretroviral Drug Resistance with Host-Targeting Drugs—First Steps towards Developing a Host-Targeting HIV-1 Assembly Inhibitor
by: Jaisri R. Lingappa, et al.
Published: (2021-03-01)

Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-Osteoporotic Drugs (Part II). The Effect of Antiosteoporotic Drugs on the Vascular Wall State
by: I. A. Skripnikova, et al.
Published: (2019-07-01)

Editorial of special column on Drug targets and drug development for Alzheimer's disease
by: Wen-Xing Ding, et al.
Published: (2022-04-01)

Enzymes as Targets for Drug Development II
by: Sung-Kun Kim
Published: (2023-02-01)

Drug Discovery and Development Targeting Dementia
by: Agnieszka Zagórska, et al.
Published: (2023-01-01)

Editorial: Biological aspects of targeted drug discovery: Development of novel targets and/or chemotherapies, and drug repurposing
by: Rajkumar Singh Kalra, et al.
Published: (2022-12-01)

Fighting Drug Resistance through the Targeting of Drug-Tolerant Persister Cells
by: Giulia De Conti, et al.
Published: (2021-03-01)

Drug treatment and novel drug target against Cryptosporidium
by: Gargala G.
Published: (2008-09-01)

Single-Walled Carbon Nanotubes Mediated Neovascularity Targeted Antitumor Drug Delivery System
by: Chengqun Chen, et al.
Published: (2013-01-01)

Recent approaches in the drug research and development of novel antimalarial drugs with new targets
by: Chinnappanna Naveen Kumar Reddy, et al.
Published: (2023-03-01)

Guest Editors of Special Column on Drug Targets and Drug Development for Alzheimer’s Disease
Published: (2022-04-01)

Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol
by: Anna M. Mc Laughlin, et al.
Published: (2021-12-01)

The cysteinome of protein kinases as a target in drug development
by: Chaikuad, A, et al.
Published: (2018)

On the importance of targeting parasite stem cells in anti-echinococcosis drug development
by: Brehm Klaus, et al.
Published: (2014-01-01)

Understanding the Microenvironment of Melanoma Cells for the Development of Target Drug Delivery Systems
by: Lucas B. Naves, et al.
Published: (2017-10-01)

Antifungal Drug Development: Targeting the Fungal Sphingolipid Pathway
by: Kyle McEvoy, et al.
Published: (2020-08-01)

Therapeutic Aspects on Mycobacterium: Mycobacterial Cell-Envelope as a Target for Drug Development
by: Ciamak Ghazaei
Published: (2022-12-01)

Targets of tumor microenvironment for potential drug development
by: Ling Zhang, et al.
Published: (2024-03-01)

New Sight: Enzymes as Targets for Drug Development
by: Sung-Kun Kim
Published: (2023-09-01)

Parasitic diarrhoeal disease: Drug development and targets
by: Amir eAzam, et al.
Published: (2015-10-01)

Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells
by: Xiaohai Song, et al.
Published: (2023-10-01)

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
by: Daniele Parisi, et al.
Published: (2020-01-01)

MODELING OF TARGETED DRUG DELIVERY PART II. MULTIPLE DRUG ADMINISTRATION
by: A. V. Zaborovskiy, et al.
Published: (2017-06-01)

Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria.
by: Anuradha Alahari, et al.
Published: (2007-12-01)

Cells and cell derivatives as drug carriers for targeted delivery
by: Halle Lutz, et al.
Published: (2019-09-01)

Importance of quantifying drug-target engagement in cells
by: Stefaniak, J, et al.
Published: (2020)

Cell-mediated targeting drugs delivery systems
by: Hongli Yu, et al.
Published: (2020-01-01)

Cell Wall Proteomics Reveal Phenotypic Adaption of Drug-Resistant Mycobacterium smegmatis to Subinhibitory Rifampicin Exposure
by: Alexander D. Giddey, et al.
Published: (2021-10-01)

Complementary Approaches to Existing Target Based Drug Discovery for Identifying Novel Drug Targets
by: Suhas Vasaikar, et al.
Published: (2016-11-01)